PharmaIntellect - Pharma Deals

by Unknown on Thursday, 23 May 2013

PharmaIntellect - Pharma Deals

Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved Voluven 6%

Posted: 22 May 2013 11:30 PM PDT

Otsuka Pharmaceutical Factory, Inc. and Fresenius Kabi Japan (FKJ) have entered into an exclusive distribution agreement in Japan, of Voluven 6%, a new to be launched HES (Hydroxyethl Starch)...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]